{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:29:18Z","timestamp":1758274158021},"reference-count":23,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2021,3,1]]},"DOI":"10.1248\/bpb.b20-00479","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T22:06:21Z","timestamp":1608329181000},"page":"332-337","source":"Crossref","is-referenced-by-count":1,"title":["Ethenzamide Exerts Protective Effects against Ibuprofen-Induced Gastric Mucosal Damage in Rats by Suppressing Gastric Contraction"],"prefix":"10.1248","volume":"44","author":[{"given":"Takato","family":"Nikaido","sequence":"first","affiliation":[{"name":"Health Science Research R&D Laboratories, Research & Development Headquarters Self-Medication, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Muroga","sequence":"additional","affiliation":[{"name":"Health Science Research R&D Laboratories, Research & Development Headquarters Self-Medication, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikashi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Health Science Research R&D Laboratories, Research & Development Headquarters Self-Medication, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Fujimaru","sequence":"additional","affiliation":[{"name":"Health Science Research R&D Laboratories, Research & Development Headquarters Self-Medication, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Asano","sequence":"additional","affiliation":[{"name":"Health Science Research R&D Laboratories, Research & Development Headquarters Self-Medication, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Takaoka","sequence":"additional","affiliation":[{"name":"Health Science Research R&D Laboratories, Research & Development Headquarters Self-Medication, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Nakamura H. Cyclooxygenase (COX)-2 selective inhibitors: aspirin, a dual COX-1\/COX-2 inhibitor, to COX-2 selective inhibitors. <i>Nihon Yakurigaku Zasshi<\/i>, <b>118<\/b>, 219\u2013230 (2001).","DOI":"10.1254\/fpj.118.219"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Takeuchi K. Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility. <i>World J. Gastroenterol.<\/i>, <b>18<\/b>, 2147\u20132160 (2012).","DOI":"10.3748\/wjg.v18.i18.2147"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Raffa RB, Clark-Vetri R, Tallarida RJ, Wertheimer AI. Combination strategies for pain management. <i>Expert Opin. Pharmacother.<\/i>, <b>4<\/b>, 1697\u20131708 (2003).","DOI":"10.1517\/14656566.4.10.1697"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Fukushima E, Monoi N, Mikoshiba S, Hirayama Y, Serizawa T, Adachi K, Koide M, Ohdera M, Murakoshi M, Kato H. Protective effects of acetaminophen on ibuprofen-induced gastric mucosal damage in rats with associated suppression of matrix metalloproteinase. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>349<\/b>, 165\u2013173 (2014).","DOI":"10.1124\/jpet.113.210021"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Nikaido T, Maruyama C, Hamanaka M, Yamaguchi C, Fujimaru Y, Nakanishi Y, Asano T, Takaoka A. Ethenzamide exerts analgesic effect at the spinal cord <i>via<\/i> multiple mechanisms of action including the 5HT<sub>2B<\/sub> receptor blockade in the rat formalin test. <i>Biol. Pharm. Bull.<\/i>, <b>43<\/b>, 839\u2013847 (2020).","DOI":"10.1248\/bpb.b19-01050"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Foguet M, Hoyer D, Pardo LA, Parekh A, Kluxen FW, Kalkman HO, St\u00fchmer W, L\u00fcbbert H. Cloning and functional characterization of the rat stomach fundus serotonin receptor. <i>EMBO J.<\/i>, <b>11<\/b>, 3481\u20133487 (1992).","DOI":"10.1002\/j.1460-2075.1992.tb05427.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Borman RA, Tilford NS, Harmer DW, Day N, Ellis ES, Sheldrick RL, Carey J, Coleman RA, Baxter GS. 5-HT<sub>2B<\/sub> receptors play a key role in mediating the excitatory effects of 5-HT in human colon <i>in vitro.<\/i> <i>Br. J. Pharmacol.<\/i>, <b>135<\/b>, 1144\u20131151 (2002).","DOI":"10.1038\/sj.bjp.0704571"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Baxter GS, Murphy OE, Blackburn TP. Further characterization of 5-hydroxytryptamine receptors (putative 5-HT<sub>2B<\/sub>) in rat stomach fundus longitudinal muscle. <i>Br. J. Pharmacol.<\/i>, <b>112<\/b>, 323\u2013331 (1994).","DOI":"10.1111\/j.1476-5381.1994.tb13072.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Shujaa N, Al-Khrasani M, Z\u00e1dori ZS, Rossi M, M\u00e1tyus P, N\u00e9meth J, Hein L, Gyires K. \u03b1<sub>(2)<\/sub>-Adrenoceptor agonist-induced inhibition of gastric motor activity is mediated by \u03b1<sub>(2A)<\/sub>-adrenoceptor subtype in the mouse. <i>Neurochem. Int.<\/i>, <b>58<\/b>, 708\u2013713 (2011).","DOI":"10.1016\/j.neuint.2011.02.011"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) F\u00fcl\u00f6p K, Z\u00e1dori Z, R\u00f3nai AZ, Gyires K. Characterisation of alpha<sub>2<\/sub>-adrenoceptor subtypes involved in gastric emptying, gastric motility and gastric mucosal defence. <i>Eur. J. Pharmacol.<\/i>, <b>528<\/b>, 150\u2013157 (2005).","DOI":"10.1016\/j.ejphar.2005.10.025"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Komada T, Yano S. Pharmacological characterization of 5-Hydroxytryptamine\u2013receptor subtypes in circular muscle from the rat stomach. <i>Biol. Pharm. Bull.<\/i>, <b>30<\/b>, 508\u2013513 (2007).","DOI":"10.1248\/bpb.30.508"},{"key":"12","unstructured":"12) Jankovi\u0107 SM, Milovanovi\u0107 DR, Jankovi\u0107 SV. Schild\u2019s equation and the best estimate of pA2 value and dissociation constant of an antagonist. <i>Croat. Med. J.<\/i>, <b>40<\/b>, 67\u201370 (1999)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Beattie DT, Smith JA, Marquess D, Vickery RG, Armstrong SR, Pulido-Rios T, McCullough JL, Sandlund C, Richardson C, Mai N, Humphrey PP. The 5-HT<sub>4<\/sub> receptor agonist, tegaserod, is a potent 5-HT<sub>2B<\/sub> receptor antagonist <i>in vitro<\/i> and <i>in vivo.<\/i> <i>Br. J. Pharmacol.<\/i>, <b>143<\/b>, 549\u2013560 (2004).","DOI":"10.1038\/sj.bjp.0705929"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ito M, Fujii A, Suzuki Y. Healing-promoting action of dried aluminium hydroxide gel evaluated by the method of histological measurements in acetic acid ulcer of rats. <i>Jpn. J. Pharmacol.<\/i>, <b>37<\/b>, 401\u2013404 (1985).","DOI":"10.1254\/jjp.37.401"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Boku K, Ohno T, Saeki T, Hayashi H, Hayashi I, Katori M, Murata T, Narumiya S, Saigenji K, Majima M. Adaptive cytoprotection mediated by prostaglandin I<sub>2<\/sub> is attributable to sensitization of CRGP-containing sensory nerves. <i>Gastroenterology<\/i>, <b>120<\/b>, 134\u2013143 (2001).","DOI":"10.1053\/gast.2001.20916"},{"key":"16","unstructured":"16) Takeuchi K. Gastric cytoprotection by prostaglandin E<sub>2<\/sub> and prostacyclin: relationship to EP1 and IP receptors. <i>J. Physiol. Pharmacol.<\/i>, <b>65<\/b>, 3\u201314 (2014)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Shibasaki J, Konishi R, Takemura M, Fukushima E, Nakamura J, Sasaki H. Comparison of the first-pass metabolism of ethenzamide and salicylamide in rats. <i>J. Pharmacobiodyn.<\/i>, <b>7<\/b>, 804\u2013810 (1984).","DOI":"10.1248\/bpb1978.7.804"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Gyires K, M\u00fcllner K, F\u00fcrst S, R\u00f3nai AZ. Alpha-<sub>2<\/sub> adrenergic and opioid receptor-mediated gastroprotection. <i>J. Physiol. Paris<\/i>, <b>94<\/b>, 117\u2013121 (2000).","DOI":"10.1016\/S0928-4257(00)00151-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Yelken B, Dorman T, Erkasap S, Dundar E, Tanriverdi B. Clonidine pretreatment inhibits stress-induced gastric ulcer in rats. <i>Anesth. Analg.<\/i>, <b>89<\/b>, 159\u2013162 (1999).","DOI":"10.1097\/00000539-199907000-00028"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Cho CH, Mei QB, Kaan SK. The intraperitoneal effects of 5-hydroxytryptamine on haemodynamics, gastric mucosal blood flow and platelet aggregation. <i>Eur. J. Pharmacol.<\/i>, <b>256<\/b>, 9\u201315 (1994).","DOI":"10.1016\/0014-2999(94)90609-2"},{"key":"21","unstructured":"21) Yasuhiro T, Konaka A, Kato S, Takeuchi K. Gastric mucosal damage induced by compound 48\/80: roles of serotonin and nitric oxide. <i>J. Gastroenterol. Hepatol.<\/i>, <b>13<\/b>, 1099\u20131106 (1998)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Tazi-Saad K, Chariot J, Del Tacca M, Roz\u00e9 C. Effect of \u03b1<sub>2<\/sub>-adrenoceptor agonists on gastric pepsin and acid secretion in the rat. <i>Br. J. Pharmacol.<\/i>, <b>106<\/b>, 790\u2013796 (1992).","DOI":"10.1111\/j.1476-5381.1992.tb14414.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Koehler PJ, Tfelt-Hansen PC. History of methysergide in migraine. <i>Cephalalgia<\/i>, <b>28<\/b>, 1126\u20131135 (2008).","DOI":"10.1111\/j.1468-2982.2008.01648.x"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/3\/44_b20-00479\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T03:27:27Z","timestamp":1615001247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/3\/44_b20-00479\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00479","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}